Boundless Bio Inc (BOLD)
9.93
-0.03
(-0.30%)
USD |
NASDAQ |
May 17, 16:00
9.93
0.00 (0.00%)
After-Hours: 17:20
Boundless Bio Total Liabilities (Quarterly): 258.26M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 258.26M |
| December 31, 2023 | 256.98M |
| September 30, 2023 | 259.78M |
| Date | Value |
|---|---|
| June 30, 2023 | 258.80M |
| December 31, 2022 | 158.52M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
158.52M
Minimum
Dec 2022
259.78M
Maximum
Sep 2023
238.47M
Average
258.26M
Median
Mar 2024
Total Liabilities (Quarterly) Benchmarks
| Syra Health Corp | 1.102M |
| Adlai Nortye Ltd | 384.03M |
| CEL-SCI Corp | 16.06M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 117.08M |
| Shareholders Equity (Quarterly) | -141.18M |